Improving management of eosinophilic esophagitis in children and adolescents
Official title: Eosinophilic Esophagitis: Towards Improved Management
Run by Oslo University Hospital · NCT06991881 · Data updated 2026-11-12
This study is trying to find better ways to manage eosinophilic esophagitis in kids and teens by using simple tests to avoid invasive procedures and improve their quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 17 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Oslo University Hospital Academic / other |
| Locations | 2 sites (Bergen and 1 other locations) |
| Status | Recruiting |
| Started | October 31, 2023 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | May 28, 2025 |
| Trial ID | NCT06991881 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children and adolescents diagnosed with eosinophilic esophagitis or those suspected of having the condition.
✕Probably not a fit
Patients with chronic severe conditions that prevent general anesthesia or those who do not provide consent may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project focuses on enhancing the care for children and adolescents diagnosed with eosinophilic esophagitis (EoE) through a collaborative effort between pediatric units at Oslo University Hospital and Helse Bergen in Norway. The study aims to systematically explore existing and new non-invasive biomarkers to reduce the need for invasive procedures like endoscopies and complex elimination diets. By identifying predictive biomarkers at diagnosis and follow-up, the study seeks to improve treatment outcomes and patient quality of life.
Why it matters
Potential benefit: If successful, this study could significantly reduce the need for invasive procedures and improve dietary management for patients with eosinophilic esophagitis.
How similar studies have gone: Other studies have shown promise in using non-invasive biomarkers for managing eosinophilic esophagitis, indicating that this approach is both relevant and potentially effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * a diagnosis of eosinophilic esophagitis * suspected but not yet confirmed eosinophilic esophagitis Exclusion Criteria: * chronic severe conditions that preclude general anaestesia * lack of consent
Where it's running
-
Haukeland University Hospital
Bergen, Norway Recruiting -
OsloUH
Oslo, Norway Recruiting
Study contacts
- Principal investigator: Ketil Størdal, PhD — University of Oslo
- Study coordinator: Ketil Størdal, PhD
- Email: ketil.stordal@medisin.uio.no
- Phone: +4748272337
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Upadacitinib for Eosinophilic Esophagitis in adults not responding to standard therapy
This study tests whether upadacitinib, taken with topical corticosteroids, can reduce disease activity in adults with eosinophilic esophagitis who still have symptoms.
-
A registry for adults with esophageal movement and reflux problems.
This project will collect esophageal function tests (manometry, pH-impedance, FLIP) and clinical data from adults with reflux or swallowing symptoms to see if combining these results helps guide diagnosis and long-term care.
-
Using a mucosal impedance device to help diagnose chronic esophageal problems
This test tries a mucosal impedance device during upper endoscopy to see if it helps diagnose people with chronic reflux (GERD) or eosinophilic esophagitis.
-
Esophageal string test to screen for eosinophilic esophagitis in adults of African descent with swallowing problems
This study will test whether a 1-hour esophageal string test can detect eosinophilic esophagitis in adults born in Africa (or with African parents) who have trouble swallowing.
-
How common FIRE is and what it looks like in children with eosinophilic esophagitis
This project will see how often and in what ways Food Induced Immediate Response of the Esophagus (FIRE) occurs in children aged 6–17 who have eosinophilic esophagitis.
-
Comparing dupilumab and topical corticosteroids for treating eosinophilic esophagitis
This study is testing whether a new weekly injection called dupilumab works better than a daily swallowed medication for treating eosinophilic esophagitis in young people aged 12 to 25.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.